Short Interest in NewGenIvf Group Limited (NASDAQ:NIVF) Decreases By 89.7%

NewGenIvf Group Limited (NASDAQ:NIVF) was the target of a significant decline in short interest in July. As of July 15th, there was short interest totaling 67,374 shares, a decline of 89.7% from the June 30th total of 654,534 shares. Based on an average daily trading volume, of 485,212 shares, the days-to-cover ratio is presently 0.1 days. Currently, 2.9% of the company’s stock are sold short.

NewGenIvf Group Trading Down 9.8%

Shares of NIVF stock traded down $0.12 during trading hours on Friday, reaching $1.10. 176,396 shares of the company’s stock were exchanged, compared to its average volume of 623,566. NewGenIvf Group has a fifty-two week low of $1.10 and a fifty-two week high of $568.53. The company has a quick ratio of 2.98, a current ratio of 3.12 and a debt-to-equity ratio of 0.16. The business has a fifty day moving average price of $1.91 and a 200-day moving average price of $7.06.

NewGenIvf Group (NASDAQ:NIVF) last announced its quarterly earnings data on Tuesday, March 31st. The company reported ($861.72) earnings per share (EPS) for the quarter. The firm had revenue of $1.42 million for the quarter. On average, equities analysts predict that NewGenIvf Group will post 14.22 earnings per share for the current year.

Analyst Ratings Changes

Several research firms recently issued reports on NIVF. Weiss Ratings reaffirmed a “sell (d)” rating on shares of NewGenIvf Group in a research note on Monday, April 27th. Wall Street Zen raised shares of NewGenIvf Group to a “hold” rating in a research report on Saturday, July 4th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Insiders Place Their Bets

In other NewGenIvf Group news, major shareholder Financial Lp Hrt acquired 45,847 shares of the firm’s stock in a transaction on Friday, May 22nd. The stock was purchased at an average cost of $2.97 per share, for a total transaction of $136,165.59. Following the transaction, the insider owned 37,295 shares of the company’s stock, valued at $110,766.15. The trade was a -536.10% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 31.80% of the company’s stock.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.